Barely Significant
← all excerpts

The combination of rifampin plus moxifloxacin is synergistic for suppression of resistance but antagonistic for cell kill of Mycobacterium tuberculosis as determined in a hollow-fiber infection model.

mBio · 2010 · PMC2925073 · PMID 20802826

Europe PMCDOI
1
hedged sentence
0.0006
closest p · 0.0× alpha
0.0006
boldest claim

The sentences

highly significantP = 0.0006actually significant
The effect of combination therapy was highly significant with regard to resistance suppression, as shown in Fig. 3 ( P = 0.0006; Breslow-Gehan test).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.